[Letter: Urokinase and surgery].
D001243:Assisted Circulation; D005112:Extracorporeal Circulation; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010689:Phlebitis / Q000188:drug therapy; D011183:Postoperative Complications; D011655:Pulmonary Embolism / Q000188:drug therapy; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D014656:Vascular Surgical Procedures
D005343:Fibrinolytic Agents; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator
Lettre: Urokinase et intervention chirurgicale